[Viral safety considerations in immunoglobulin preparations].
Gómez Manzano
P
P
Instituto de Salud Carlos III, Departamento de Productos Biológicos, Madrid.
Escrivá
C A
CA
Salmerón García
F
F
Alonso Verduras
C
C
D000914:Antibodies, Viral / Q000097:blood; D015415:Biomarkers; D001782:Blood Donors; D005591:Chemical Fractionation; D003902:Detergents / Q000494:pharmacology; D005062:European Union; D006358:Hot Temperature; D006801:Humans; D007136:Immunoglobulins / Q000008:administration & dosage; D016756:Immunoglobulins, Intravenous / Q000592:standards*; D007273:Injections, Intramuscular; D012698:Serologic Tests; D012997:Solvents / Q000494:pharmacology; D013242:Sterilization / Q000379:methods; D014462:Ultrafiltration; D014766:Viremia / Q000097:blood; D014777:Virus Diseases / Q000097:blood / Q000517:prevention & control* / Q000635:transmission; D014780:Viruses / Q000187:drug effects
D000914:Antibodies, Viral; D015415:Biomarkers; D003902:Detergents; D007136:Immunoglobulins; D016756:Immunoglobulins, Intravenous; D012997:Solvents